Skip to main content
The Ramco Cements Limited logo

The Ramco Cements Limited — Investor Relations & Filings

Ticker · RAMCOCEM ISIN · INE331A01037 LEI · 3358003MPDJN515PDG51 BSE.NS Manufacturing
Open in API
Filings indexed 1,583 across all filing types
Latest filing 2025-08-07 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS RAMCOCEM

About The Ramco Cements Limited

https://www.ramcocements.in/

The Ramco Cements Limited is a prominent manufacturer specializing in the production of cement, ready-mix concrete, and dry mortar products. The company offers a diverse portfolio including Ordinary Portland Cement, Portland Pozzolana Cement, and Portland Slag Cement, alongside specialized brands such as Ramco Supergrade and Ramco Supercrete. Its operations are characterized by the integration of advanced manufacturing technologies and a strong emphasis on research and development conducted through dedicated centers. The company serves a wide range of construction needs across residential, commercial, and infrastructure sectors. By prioritizing the production of blended cements and high-performance building materials, it focuses on delivering structural durability and environmental sustainability. Its technical expertise and quality control processes ensure the delivery of specialized solutions tailored to specific engineering requirements.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 92% confidence The document is the Unaudited Standalone and Consolidated Statement of Profit and Loss for the quarter ended 30 June 2025, includes full financial tables and detailed notes, and is presented under SEBI LODR regulations following a board meeting. This goes beyond an earnings highlight and contains substantive financial statements and auditor review, fitting the definition of an Interim/Quarterly Report (IR). Q1 2026
2025-08-07 English
Unaudited standalone and consolidated results for the quarter ended 30.06.2025 and Acquisition of shares of Ramco Windfarms Limited
Regulatory Filings
2025-08-07 English
Outcome of Board Meeting
Regulatory Filings
2025-08-07 English
closure of trading window
Regulatory Filings Classification · 95% confidence The document is a letter from the company to stock exchanges informing about an upcoming Board Meeting scheduled to consider the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. It also mentions the closure of the trading window for insiders. The document is dated July 28, 2025, and is a notification of a future event (board meeting and trading window closure) rather than the actual financial results or report. The document length is short (2121 characters) and does not contain any financial data or detailed analysis. It is an announcement related to the scheduling of a board meeting and compliance with SEBI regulations. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into other specific categories like Interim Report or Earnings Release, which would require actual financial data or results.
2025-07-28 English
The Ramco Cements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve board meeting on 07-8-2025
Regulatory Filings Classification · 95% confidence The document is a letter from The Ramco Cements Limited addressed to stock exchanges, dated 28 July 2025. It announces a forthcoming Board Meeting scheduled for 7 August 2025 to consider the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025. It also informs about the closure of the trading window for directors and designated persons until 11 August 2025. The document does not contain the financial results themselves, only an announcement of the meeting to consider those results and related compliance information. The document length is short (2121 characters) and it is clearly an announcement rather than the actual interim or quarterly report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice, not as the Interim/Quarterly Report (IR) itself.
2025-07-28 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter from the company to stock exchanges informing about an upcoming Board Meeting scheduled to consider the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. It also mentions the closure of the trading window for insiders. The document does not contain the actual financial results or detailed financial data but is an announcement of the meeting where such results will be considered. The document length is short (2117 characters) and it serves as a notification rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance notice rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2025-07-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.